Similarly, TGF-β treatment upregulated mRNA expression of a number of inositol transporters such as SLC5A3 and SLC5A11 (Additional file 1: Fig. S1B), supporting the concept of dysregulated inositol transport and metabolism in IPF pathogenesis. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.